Clinical Trial Update: Systemic Chemotherapy Plus Lenvatinib and Toripalimab for HCC With Extrahepatic Metastasis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating systemic chemotherapy plus lenvatinib and toripalimab for hepatocellular carcinoma with extrahepatic metastasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Lenvatinib (lenvatinib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN